EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS

Yi Zhu, Meiling Chen, Chuangzan Yang, Geng Lu, Sa Huang iD, Meili Chen, Yufei Wang, Junfeng Ban iD

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s461969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Yi Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Pharmaceutical University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Celecoxib, Hyaluronic Acid, Biological Availability, Drug Carriers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CelecoxibHyaluronic AcidBiological AvailabilityDrug CarriersLipidsRats, Sprague-DawleyNanostructuresTandem Mass SpectrometryAnimalsRatsMaleChromatography, High Pressure LiquidAdministration, OralLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

HPLC-MS/MScelecoxibnanostructured lipid carrierspharmacokinetics

Substanzen

CelecoxibHyaluronic AcidDrug CarriersLipids

Autor:innen und Institutionen

  • Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
  • The Innovation Team for Integrating Pharmacy with Entrepreneurship, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
  • Guangdong Laboratory Animals Monitoring Institute, Guangdong Provincial Key Laboratory of Laboratory Animals, Guangzhou, People's Republic of China.
  • Analytical and Testing Center of Guangzhou University, Guangzhou, People's Republic of China.

ORCID-Profile: Sa Huang, Junfeng Ban

Zitieren

APA

Zhu, Y., Chen, M., Yang, C., Lu, G., Huang, S., Chen, M., Wang, Y., & Ban, J. (2024). Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s461969

Vancouver

Zhu Y, Chen M, Yang C, Lu G, Huang S, Chen M, et al. Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s461969

BibTeX
@article{Zhu2024,
  author = {Zhu, Yi and Chen, Meiling and Yang, Chuangzan and Lu, Geng and Huang, Sa and Chen, Meili and Wang, Yufei and Ban, Junfeng},
  title = {Revealing Changes in Celecoxib Nanostructured Lipid Carrier’s Bioavailability Using Hyaluronic Acid as an Enhancer by HPLC-MS/MS},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s461969}
}
Kostenlos starten →